Key facts
- Notable investors include Shenzhen Capital Group, Suzhou Guofa Venture Capital, Shanghai Rui Investment Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Minimally Invasive Regenerative Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for Minimally Invasive Regenerative Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Minimally Invasive Regenerative Medicine
Developer of minimally invasive restorative intended for clinical restoration across bone, skin, cartilage, nerve, oral, and sports-care applications. The company provides advanced biomaterials and collaborative development, enabling healthcare industry users with safe and efficient treatment solutions.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Minimally Invasive Regenerative Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Minimally Invasive Regenerative Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Minimally Invasive Regenerative Medicine in its N-PORT filings yet. We sweep new filings monthly.